"We are excited to see Pfizer advancing MesoC2 into clinical development rapidly, highlighting the potential of Nona's Harbour Mice® and integrated ADC platforms to deliver innovative cancer therapies ...
HepQuant, a leader in developing noninvasive, blood-based, quantitative testing to assess liver health, presented oral and ...
Clinical trials are well-controlled and designed experiments that aim to prove that an Investigational Medicinal Product (IMP) is effective. Clinical trial data is submitted to the national health ...
The MarketWatch News Department was not involved in the creation of this content. CAMBRIDGE, Mass., May 23, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback